Presentations to Focus on Risk Factors and Biomarkers in Head and Neck Cancers
NEW YORK (July 25, 2014) – Clinicians and researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present new findings from eight abstracts at the International Federation of Head and Neck Oncologic Societies World Congress (IFHNOS) being held July 26 – July 30 in New York. Data includes discoveries of risk factors for head and neck carcinomas and reveal pretreatment body mass as a significant predictor of head and neck cancer survival rates. A head and neck cancer diagnosis occurs every 10 minutes in the United States, though symptoms usually appear only in advanced stages.
"Head and neck squamous cell carcinomas can have a poor prognosis in some patients," said Richard V. Smith, M.D., F.A.C.S, director, Head and Neck Service, Montefiore Einstein Center for Cancer Care and professor and vice chairman, Department of Otorhinolaryngology-Head and Neck Surgery and professor of Pathology and Surgery, Einstein. "The research we are presenting furthers our knowledge of risk factors associated with poor head and neck cancer outcomes and may enable improved monitoring and management of disease progression. We look forward to sharing these important data with our colleagues at this prestigious meeting."
This year's conference will feature lectures, oral abstracts and poster presentations made by nationally and internationally renowned otolaryngologists, head and neck surgeons, oncologists and researchers. Investigator findings focus on biomarkers that may predict survival from head and neck cancers.
Following is a sample of Montefiore-Einstein studies to be presented at the meeting, all of which are embargoed until the time of presentation. Investigators are available for interviews specific to the data or to comment on topics of interest coming out of IFHNOS 2014: